Ajay Sharma's research while affiliated with Delhi Institute of Pharmaceutical Sciences and Research and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (5)
Rheumatoid arthritis is a hyperactive immune disorder that results in severe inflammation in synovial joints, cartilage, and bone deterioration, resulting in immobilization of joints. Traditional approaches for the treatment of rheumatoid arthritis are associated with some limiting factors such as suboptimal patient compliance, inability to control...
Nanotechnology has revolutionized cancer diagnosis and therapy through targeted drug delivery. Advances in protein engineering and materials science have led to the development of nanocarriers (NCs), which have helped overcome the challenges faced during conventional cancer treatment. These nanocarriers serve as an efficient transport module for dr...
Cancer is one of the deadliest diseases associated with high mortality, and treatment options are limited and conventional drug used in treatment of cancer face various challenges like poor solubility and lower circulation period in plasma and these challenges are addressed by nanocarriers aid in improving the pharmacological action-based efficacy...
Rapid advancements in the field of anticancer vaccination paved the way for recognizing several targets to stimulate an immune response against one or multiple tumor-associated antigens (TAAs). Tumor-specific immune activation is specifically dependent upon a tumor-reactive T-lymphocyte response. Peptide-based vaccines targeting T-cells are one of...
Citations
... In affluent countries, the prevalence of this illness among adults (which affects women more than men) varies between 0.5 and 1% during their working life IL-6, IL-1, MMPs and TNF-α may cause the synovial lining to thicken and fibroblast-like synoviocytes to increase, leading to synovitis. RA therapy options have proven to be effective; however, research now focuses on creating cutting-edge medicines to surpass the adverse effects of dose escalation-induced defunctionalization and therapeutic tolerance [2]. Due to their poorly soluble nature, large dosages, increased toxic nature, shorter halflives and unspecific administration routes, conventional therapeutics have a limited range of applications. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/272190675353611-1441906722228_Q64/Pramod-Kumar-19.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/980148723646469-1610697074638_Q64/Madhu-Gupta-4.jpg)
